Key Market Indicators
By 2026, the prevalence of HIV/AIDS among those aged 0-14 in Gabon is expected to decline to 2,830 individuals from 2,930 in 2021. This marks an average yearly decrease of 0.9% since 1995, dropping the country to 43rd place in the global ranking in 2021. Nigeria, Mozambique, and Tanzania ranked second, third, and fourth respectively. Meanwhile, Gabon's treatment coverage of HIV/AIDS is projected to increase to 68% of those living with HIV from 57% in 2021. This represents an average yearly rise of 2.2 points since 2007, placing the nation in 89th position in 2021. Cape Verde, Latvia, and Zimbabwe all ranked higher in the global ranking.
Gabon HIV AIDS Market Data and Forecasts
How much will Gabon HIV AIDS Market grow to 2026?
More in HIV AIDS Industry for 2028Improve your Knowledge with the latest Indicators and Trends
-
HIV Treatment Sector: Comprehensive Analysis of Therapeutic Advancements and Opportunities
The modern HIV treatment landscape has been remodelled by the introduction of revolutionary drugs and therapeutic interventions focusing on improved patient compliance and reduced side effects. Antiretroviral therapy (ART) has notably evolved, with a surge of new drug categories, such as integrase inhibitors, showing remarkable efficacy. There has also been...
Discover more insights -
HIV Market Access Impact: Influential Points & Comprehensive Perspectives
The influence within the HIV market is primarily driven by multiple factors. Key among them includes the level of pharmaceutical innovation, the prevalence of the disease, and the nature of funding for treatment and research. Pharmaceutical companies have been more amicable towards investing in the development of groundbreaking treatments, paving...
Discover more insights